Quantum Radiance LLC – Trademark Portfolio

Entity Type: 16

Quantum Radiance LLC holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include KA!. The owner is based in New York, NY.

305 2nd Ave, Suite 306

New York, NY 10003

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

KA!
KA!
Registered 2021
KA!
KA!
Registered 2021

Trademark Classifications

Quantum Radiance LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (3 filings)

Advertising; business management; business administration; office functions

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Quantum Radiance LLC have?

Quantum Radiance LLC has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does Quantum Radiance LLC file in?

Quantum Radiance LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.

What are Quantum Radiance LLC's most well-known trademarks?

Quantum Radiance LLC's registered trademark portfolio includes well-known marks such as KA!. These are among 2 currently registered trademarks in the portfolio.

What is Quantum Radiance LLC's trademark registration success rate?

Quantum Radiance LLC has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.